,i #aaith ,,congress #b;d ,session ,h4 ,r4 #ijfa ,,in ,,the ,,house ,,of ,,representatives ,may #bi1 #bjbf,mr4 ,kean 7for himself1 ,ms4 ,kelly of ,illinois1 ,mrs4 ,kiggans of ,virginia1 and ,ms4 ,clarke of ,new ,york7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend title ,,xix of the ,social ,security ,act to require the ,secretary of ,health and ,human ,services to issue guidance to ,states on which tests for the screening and early detection of preeclampsia may be covered under the ,medicaid program and the ,children's ,health ,insurance ,program4 #a4 ,short title ,this ,act may be cited as the ,preeclampsia ,risk ,evaluation and ,evidence-based ,management through ,personalized ,testing ,act or the ,,preempt ,act4 #b4 ,findings ,congress finds the following3 7#a7 ,according to the ,centers for ,disease ,control and ,prevention1 preeclampsia affects approximately #e to #h percent of pregnancies globally1 with #gj1jjj maternal deaths and #ejj1jjj fetal deaths each year in the ,united ,states4 7#b7 ,in the ,united ,states1 ,black women are at least three times more likely to die due to a pregnancy-related cause when compared to ,white women4 7#c7 ,preeclampsia and related cardiovascular and hypertensive disorders of pregnancy are one of the leading causes of maternal mortality and morbidity in the ,united ,states1 contributing to up to #ae percent of all maternal deaths1 particularly in ,states with the highest-risk populations and in low resource settings4 7#d7 ,preeclampsia is a major contributor to preterm births1 accounting for about #ae to #bj percent of all preterm deliveries in the ,united ,states4 7#e7 ,the annual economic burden of preeclampsia in the ,united ,states exceeds #b billion1 including both direct health care costs to mother and baby1 and indirect losses due to long-term health complications and lost productivity4 7#f7 ,risk factors for preeclampsia include maternal age1 pre-existing diabetes1 pregnancies with multiples1 chronic hypertension1 obesity1 multiple pregnancies1 and certain autoimmune diseases1 all of which can increase the likelihood of developing this condition4 7#g7 ,women who develop preeclampsia during pregnancy have an elevated risk of long-term cardiovascular complications1 including chronic hypertension1 heart disease and stroke4 #c4 ,guidance on ,medicaid coverage of preeclampsia screening and detection tests ,title ,,xix of the ,social ,security ,act 7#db ,u4,s4,c4 #acif et seq47 is amended by inserting after section #aidh the following new section3 #aidi4 ,guidance and technical assistance with respect to coverage of preeclampsia screening and detection tests 7a7 ,guidance ,not later than the date that is #ahj days after the date of the enactment of this section1 the ,secretary shall issue guidance to ,states and1 as appropriate1 medicaid managed care organizations1 on-- 7#a7 best practices for improving outcomes for pregnant women with preeclampsia who are eligible for and receiving medical assistance under a ,state plan 7or waiver of such plan7 under this title or a ,state child health plan 7or waiver of such plan7 under title ,,xxi through early screening1 detection1 and management2 and 7#b7 which tests for the early detection of preeclampsia may be furnished to such pregnant women as medical assistance under such a ,state plan 7or waiver7 or such a ,state child health plan 7or waiver71 including whether the biomarker tests described in subsection 7c7 may be so furnished4 7b7 ,technical assistance 7#a7 ,in general ,the ,secretary shall1 not later than #cj days after receipt of a request from a ,state for technical assistance with respect to determining whether a ,state plan or ,state child health plan may provide medical assistance for a specific test for the early detection of preeclampsia1 including a biomarker test described in subsection 7c71 provide such technical assistance to such ,state4 7#b7 ,rule of construction ,nothing in this subsection shall be construed as creating a requirement for a ,state to request or receive the technical assistance described in paragraph 7#a7 as a condition of providing medical assistance for a specific test for the early detection of preeclampsia1 or of receiving ,federal financial participation for such medical assistance4 7c7 ,biomarker tests ,to be considered ,for purposes of this section1 the ,secretary shall consider advanced biomarker tests for the early detection of preeclampsia1 including any such test that is regulated and cleared under the ,federal ,food1 ,drug1 and ,cosmetic ,act as a device 7as defined in section #bja7;h7 of such ,act71 and any such laboratory-developed testing service furnished by a clinical laboratory that is certified under section #cec of the ,public ,health ,service ,act to perform high-complexity testing4 4